Terms: = Prostate cancer AND HLF, Q16534, 3131, ENSG00000108924 AND Diagnosis
3 results:
1. RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy.
Strand SH; Switnicki M; Moller M; Haldrup C; Storebjerg TM; Hedegaard J; Nordentoft I; Hoyer S; Borre M; Pedersen JS; Wild PJ; Park JY; Orntoft TF; Sorensen KD
Oncotarget; 2017 Jan; 8(4):5774-5788. PubMed ID: 28052017
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of qualitative and quantitative approach to prostate MR spectroscopy in peripheral zone cancer detection.
Klijn S; De Visschere PJ; De Meerleer GO; Villeirs GM
Eur J Radiol; 2012 Mar; 81(3):411-6. PubMed ID: 21215541
[TBL] [Abstract] [Full Text] [Related]
3. Utilisation of radiotherapy in rural and urban areas in British Columbia compared with evidence-based estimates of radiotherapy needs for patients with breast, prostate and lung cancer.
Tyldesley S; McGahan C
Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):526-32. PubMed ID: 20594811
[TBL] [Abstract] [Full Text] [Related]
